BPC-157: what the research says
BPC-157 is one of the most studied peptides in the preclinical research literature. This page summarises, neutrally and factually, what in-vitro research documents about it. It is not usage advice: these products are intended solely for scientific laboratory research, not for human consumption.
What is BPC-157?
BPC-157 (Body Protection Compound) is a 15-amino-acid pentadecapeptide derived from a sequence identified in a gastric juice protein. It is supplied lyophilised (stabilised powder) with an independent certificate of analysis (HPLC + mass spectrometry) stating per-batch purity and content.
Documented research directions
In in-vitro and preclinical models, BPC-157 is used as a tool to study angiogenesis and growth-factor expression. This is fundamental research: it allows no extrapolation to human use and describes no established therapeutic effect.
Stability and laboratory handling
The lyophilised form allows long-term storage. In the lab, reconstitution is done with bacteriostatic water; the resulting solution is kept refrigerated. A reconstitution calculator is available on the site to prepare study concentrations.
Regulatory framing
BPC-157 is offered exclusively as a research reagent (Research Use Only). It is not intended for human consumption, nor for the diagnosis, treatment or prevention of any disease.
FAQ
- Is BPC-157 a medicine?
- No. It is a research peptide, supplied as a laboratory reagent. It has no marketing authorisation and is not intended for human use.
- How is batch quality verified?
- Each batch comes with an independent certificate of analysis (HPLC + mass spectrometry) stating purity and content. Certificates are available on the Analyses page.
- In what form is it delivered?
- As a lyophilised powder, to be reconstituted in the lab with bacteriostatic water for study purposes.
Sources
Research peptides — Research Use Only
- Not for human consumption
- Not for the diagnosis, treatment or prevention of any disease